MA

Mohammed Arqamuddin Akhter

Active Director Director DIN 08720282
DIN 08720282 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammed Arqamuddin Akhter

Data last updated:

Mohammed Arqamuddin Akhter is a Director at Greenside Pharma Private Limited (since 2020). The company operates in Pharma.

DIN 08720282
Primary Designation Director
Industry Pharma
First Appointment 11 Mar 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Greenside Pharma Private Limited U24119TG2020PTC139716
Director11 Mar 20202020Active

Board colleagues of Mohammed Arqamuddin Akhter

NameDINCompanyDesignation
Syed Emad Mohiuddin08720281Greenside Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Greenside Pharma Private Limited
Premium access

Shareholding and investment profile for Mohammed Arqamuddin Akhter

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Arqamuddin Akhter

Mohammed Arqamuddin Akhter currently holds 1 directorship: Greenside Pharma Private Limited (Director, since 11 Mar 2020).

Mohammed Arqamuddin Akhter was first appointed on 11 Mar 2020 as Director at Greenside Pharma Private Limited.

The current boards of Mohammed Arqamuddin Akhter's companies include Syed Emad Mohiuddin (Greenside Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available